-
Something wrong with this record ?
The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice
M. Hensler, K. Bardova, ZM. Jilkova, W. Wahli, D. Meztger, P. Chambon, J. Kopecky, P. Flachs,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
BioMedCentral
from 2002-12-01
BioMedCentral Open Access
from 2002
Directory of Open Access Journals
from 2002
Free Medical Journals
from 2002
PubMed Central
from 2002
Europe PubMed Central
from 2002
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-09-01
Open Access Digital Library
from 2002-01-01
Medline Complete (EBSCOhost)
from 2002-09-03
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2002
Springer Nature OA/Free Journals
from 2002-12-01
- MeSH
- Prostaglandin-Endoperoxide Synthases genetics metabolism MeSH
- Epididymis metabolism pathology MeSH
- Gene Expression MeSH
- Gene Knockout Techniques MeSH
- Corn Oil adverse effects MeSH
- Mice, Transgenic MeSH
- Mice MeSH
- Obesity chemically induced prevention & control MeSH
- Fatty Acids, Omega-3 pharmacology MeSH
- PPAR alpha genetics metabolism MeSH
- PPAR gamma genetics MeSH
- Drug Evaluation, Preclinical MeSH
- Cell Proliferation drug effects MeSH
- Proteins genetics metabolism MeSH
- Stearoyl-CoA Desaturase genetics metabolism MeSH
- Trans-Activators genetics metabolism MeSH
- Adipocytes drug effects pathology MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) of marine origin exert multiple beneficial effects on health. Our previous study in mice showed that reduction of adiposity by LC n-3 PUFA was associated with both, a shift in adipose tissue metabolism and a decrease in tissue cellularity. The aim of this study was to further characterize the effects of LC n-3 PUFA on fat cell proliferation and differentiation in obese mice. METHODS: A model of inducible and reversible lipoatrophy (aP2-Cre-ERT2 PPARγL2/L2 mice) was used, in which the death of mature adipocytes could be achieved by a selective ablation of peroxisome proliferator-activated receptor γ in response to i.p. injection of tamoxifen. Before the injection, obesity was induced in male mice by 8-week-feeding a corn oil-based high-fat diet (cHF) and, subsequently, mice were randomly assigned (day 0) to one of the following groups: (i) mice injected by corn-oil-vehicle only, i.e."control" mice, and fed cHF; (ii) mice injected by tamoxifen in corn oil, i.e. "mutant" mice, fed cHF; (iii) control mice fed cHF diet with15% of dietary lipids replaced by LC n-3 PUFA concentrate (cHF+F); and (iv) mutant mice fed cHF+F. Blood and tissue samples were collected at days 14 and 42. RESULTS: Mutant mice achieved a maximum weight loss within 10 days post-injection, followed by a compensatory body weight gain, which was significantly faster in the cHF as compared with the cHF+F mutant mice. Also in control mice, body weight gain was depressed in response to dietary LC n-3 PUFA. At day 42, body weights in all groups stabilized, with no significant differences in adipocyte size between the groups, although body weight and adiposity was lower in the cHF+F as compared with the cHF mice, with a stronger effect in the mutant than in control mice. Gene expression analysis documented depression of adipocyte maturation during the reconstitution of adipose tissue in the cHF+F mutant mice. CONCLUSION: Dietary LC n-3 PUFA could reduce both hypertrophy and hyperplasia of fat cells in vivo. Results are in agreement with the involvement of fat cell turnover in control of adiposity.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12028134
- 003
- CZ-PrNML
- 005
- 20121207122927.0
- 007
- ta
- 008
- 120817e20110802enk f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1186/1476-511x-10-128 $2 doi
- 035 __
- $a (PubMed)21810216
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hensler, Michal $u Department of Adipose Tissue Biology, Institute of Physiology Academy of Sciences of Czech Republic v.v.i., Prague, Czech Republic.
- 245 14
- $a The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice / $c M. Hensler, K. Bardova, ZM. Jilkova, W. Wahli, D. Meztger, P. Chambon, J. Kopecky, P. Flachs,
- 520 9_
- $a BACKGROUND: Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) of marine origin exert multiple beneficial effects on health. Our previous study in mice showed that reduction of adiposity by LC n-3 PUFA was associated with both, a shift in adipose tissue metabolism and a decrease in tissue cellularity. The aim of this study was to further characterize the effects of LC n-3 PUFA on fat cell proliferation and differentiation in obese mice. METHODS: A model of inducible and reversible lipoatrophy (aP2-Cre-ERT2 PPARγL2/L2 mice) was used, in which the death of mature adipocytes could be achieved by a selective ablation of peroxisome proliferator-activated receptor γ in response to i.p. injection of tamoxifen. Before the injection, obesity was induced in male mice by 8-week-feeding a corn oil-based high-fat diet (cHF) and, subsequently, mice were randomly assigned (day 0) to one of the following groups: (i) mice injected by corn-oil-vehicle only, i.e."control" mice, and fed cHF; (ii) mice injected by tamoxifen in corn oil, i.e. "mutant" mice, fed cHF; (iii) control mice fed cHF diet with15% of dietary lipids replaced by LC n-3 PUFA concentrate (cHF+F); and (iv) mutant mice fed cHF+F. Blood and tissue samples were collected at days 14 and 42. RESULTS: Mutant mice achieved a maximum weight loss within 10 days post-injection, followed by a compensatory body weight gain, which was significantly faster in the cHF as compared with the cHF+F mutant mice. Also in control mice, body weight gain was depressed in response to dietary LC n-3 PUFA. At day 42, body weights in all groups stabilized, with no significant differences in adipocyte size between the groups, although body weight and adiposity was lower in the cHF+F as compared with the cHF mice, with a stronger effect in the mutant than in control mice. Gene expression analysis documented depression of adipocyte maturation during the reconstitution of adipose tissue in the cHF+F mutant mice. CONCLUSION: Dietary LC n-3 PUFA could reduce both hypertrophy and hyperplasia of fat cells in vivo. Results are in agreement with the involvement of fat cell turnover in control of adiposity.
- 650 _2
- $a tukové buňky $x účinky léků $x patologie $7 D017667
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a kukuřičný olej $x škodlivé účinky $7 D003314
- 650 _2
- $a preklinické hodnocení léčiv $7 D004353
- 650 _2
- $a epididymis $x metabolismus $x patologie $7 D004822
- 650 _2
- $a omega-3 mastné kyseliny $x farmakologie $7 D015525
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a genový knockout $7 D055786
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši transgenní $7 D008822
- 650 _2
- $a obezita $x chemicky indukované $x prevence a kontrola $7 D009765
- 650 _2
- $a PPAR alfa $x genetika $x metabolismus $7 D047493
- 650 _2
- $a PPAR gama $x genetika $7 D047495
- 650 _2
- $a cyklooxygenasy $x genetika $x metabolismus $7 D011451
- 650 _2
- $a proteiny $x genetika $x metabolismus $7 D011506
- 650 _2
- $a stearyl-CoA-desaturasa $x genetika $x metabolismus $7 D013230
- 650 _2
- $a trans-aktivátory $x genetika $x metabolismus $7 D015534
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bardova, Kristina
- 700 1_
- $a Jilkova, Zuzana Macek
- 700 1_
- $a Wahli, Walter
- 700 1_
- $a Meztger, Daniel
- 700 1_
- $a Chambon, Pierre
- 700 1_
- $a Kopecky, Jan
- 700 1_
- $a Flachs, Pavel
- 773 0_
- $w MED00008241 $t Lipids in health and disease $x 1476-511X $g Roč. 10(20110802), s. 128
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21810216 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121207123001 $b ABA008
- 999 __
- $a ok $b bmc $g 950176 $s 785480
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 10 $d 128 $e 20110802 $i 1476-511X $m Lipids in health and disease $n Lipids Health Dis $x MED00008241
- LZP __
- $a Pubmed-20120817/11/04